Fermosa Bio Private Limited
About Fermosa Bio Private Limited
Data last updated:
Fermosa Bio Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC373976. Its GSTIN is 29AAECF8661R1ZN (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Mahammadhasan Gulamali Momin and Shamrao Dhannure.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 128 Prestige Ind. Estate Bavdi Lane Near Hdfc Bank Marve Road Malad West, Mumbai, Maharashtra, India – 400064.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.16 Cr, a growth of 106% compared to the previous year. For the same year it recorded a net profit of ₹2.01 Cr (net margin 39%) and EBITDA of ₹2.42 Cr (EBITDA margin 47%).
As per MCA filings, the company has open charges of ₹2.65 Cr on record.
Company details
Contact details
Fermosa Bio Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address128 Prestige Ind. Estate Bavdi Lane Near Hdfc Bank Marve Road Malad West, Mumbai, Maharashtra, India – 400064
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Fermosa Bio Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fermosa Bio is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Fermosa Bio Private Limited, buy the company report.
Financials of Fermosa Bio Private Limited
FY 2025 filings availableFermosa Bio Private Limited reported revenue of ₹5.16 Cr (up 106% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 106% in the latest year. EBITDA rose 105% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.42 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.01 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 47% | |||
| Net Profit Margin | 39% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Fermosa Bio Private Limited, buy the company report.
Board of directors of Fermosa Bio Private Limited
Fermosa Bio has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahammadhasan Gulamali Momin | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
| Shamrao Dhannure | Director | 27 Dec 2021 | 4 Years 10 Months | Current |
| Hardik Ajay Dani | Director | 27 Dec 2021 | 4 Years 10 Months | Current |
| Nishith Ramesh Zatakia | Director | 27 Dec 2021 | 4 Years 10 Months | Current |
| Piyush Krishnakant Modi | Director | 27 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Fermosa Bio Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Optime Specialities Private Limited | ₹5.18 Cr (FY 2025) | 1808.0% | Thane, Maharashtra, India | |||
| Upico Medicare Private Limited | ₹5.18 Cr (FY 2025) | 28.0% | Delhi, India | |||
| Manish Labchem Private Limited | ₹5.18 Cr (FY 2025) | 9.0% | Vapi, Gujarat, India | |||
| Smitha Petrochemicals Private Limited | ₹5.17 Cr (FY 2025) | 42.0% | Panvel, Maharashtra, India | |||
| Anbr Elixir Private Limited | ₹5.17 Cr (FY 2024) | 17.0% | Ankleshwar, Gujarat, India | |||
| Fermosa Bio Private Limitedthis company | ₹5.16 Cr (FY 2025) | ₹2.01 Cr | 39% | 106.0% | Mumbai, Maharashtra, India | |
| Afcil Industries Limited | ₹5.16 Cr (FY 2018) | 2284.0% | Pune, Maharashtra, India | |||
| Kuttuva Silicates Private Limited | ₹5.15 Cr (FY 2024) | -11.0% | Madurai, Tamil Nadu, India | |||
| Dna Agrotech Private Limited | ₹5.15 Cr (FY 2024) | -50.0% | Assam, India | |||
| Tanmay Traders Private Limited | ₹5.15 Cr (FY 2025) | -1.0% | Surat, Gujarat, India | |||
| Vaishvanar Organics Private Limited | ₹5.15 Cr (FY 2024) | -23.0% | Gujarat, India |
To see the full peer comparison of Fermosa Bio Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2024 | 100915749 | Others | ₹2.5 Cr | Open | |
| 30 Mar 2024 | 100916396 | Others | ₹15 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Fermosa Bio Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fermosa Bio Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fermosa Bio Private Limited has 1 active EPFO establishment as of Apr 10, 2024.
GST
Fermosa Bio has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECF8661R1ZN | Karnataka | Active | 13 Apr 2022 |
To see the full GST registrations and return filing status of Fermosa Bio Private Limited, buy the company report.
Recent activity
Fermosa Bio Private Limited has 7 board changes on record since 2021: 5 appointments and 2 cessations. The latest: Mahammadhasan Gulamali Momin was appointed as Director on 10 Jan 2024.
Frequently asked questions
Fermosa Bio is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 December 2021 (5+ years old) and is registered under CIN U24290MH2021PTC373976.
Fermosa Bio has 5 current directors:
- Mahammadhasan Gulamali Momin - Director
- Shamrao Dhannure - Director
- Hardik Ajay Dani - Director
- Nishith Ramesh Zatakia - Director
- Piyush Krishnakant Modi - Director
The latest financial statements of Fermosa Bio on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Fermosa Bio is 29AAECF8661R1ZN, registered in Karnataka.
The CIN (Corporate Identification Number) of Fermosa Bio is U24290MH2021PTC373976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fermosa Bio was incorporated on 27 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Fermosa Bio by revenue are Optime Specialities Private Limited, Upico Medicare Private Limited, Manish Labchem Private Limited, Smitha Petrochemicals Private Limited, Anbr Elixir Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mahammadhasan Gulamali Momin was appointed as Director on 10 Jan 2024. Hireniben Rushikumar Bhatt ceased to be Additional Director on 30 Sep 2022. Mahammadhasan Gulamali Momin ceased to be Additional Director on 30 Sep 2022. Fermosa Bio has 7 board changes on record in total.
The registered office of Fermosa Bio is at 128 Prestige Ind. Estate Bavdi Lane Near Hdfc Bank Marve Road Malad West, Mumbai, Maharashtra, India – 400064.
Fermosa Bio operates in the chemicals industry, in the manufacturing segment.
Fermosa Bio has open charges of ₹2.65 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
